DGM-CM6: A New Model to Predict Distant Recurrence Risk in Operable Endocrine-Responsive Breast Cancer.

Lei, Lei; Wang, Xiao-Jia; Mo, Yin-Yuan; Cheng, Skye Hung-Chun; Zhou, Yunyun

Lei, Lei; Wang, Xiao-Jia; Mo, Yin-Yuan; Cheng, Skye Hung-Chun; Zhou, Yunyun.

Afiliação

Lei L; Department of Breast Medical Oncology, Chinese Academy of Sciences University Cancer Hospital (Zhejiang Cancer Hospital), Hangzhou, China.
Wang XJ; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, MS, United States.
Mo YY; Department of Breast Medical Oncology, Chinese Academy of Sciences University Cancer Hospital (Zhejiang Cancer Hospital), Hangzhou, China.
Cheng SH; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, MS, United States.
Zhou Y; Department of Radiation Oncology, Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan.

Front Oncol ; 10: 783, 2020.

Article em En | MEDLINE | ID: mdl-32528885

Palavras-chave

breast cancer; clinical-genomic model; distant recurrence; endocrine-responsive; prognosis

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google